ATR Regulates Fragile Site Stability

Conditions that partially inhibit DNA replication induce expression of common fragile sites. These sites form gaps and breaks on metaphase chromosomes and are deleted and rearranged in many tumors. Yet, the mechanism of fragile site expression has been elusive. We demonstrate that the replication ch...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cell 2002-12, Vol.111 (6), p.779-789
Hauptverfasser: Casper, Anne M., Nghiem, Paul, Arlt, Martin F., Glover, Thomas W.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 789
container_issue 6
container_start_page 779
container_title Cell
container_volume 111
creator Casper, Anne M.
Nghiem, Paul
Arlt, Martin F.
Glover, Thomas W.
description Conditions that partially inhibit DNA replication induce expression of common fragile sites. These sites form gaps and breaks on metaphase chromosomes and are deleted and rearranged in many tumors. Yet, the mechanism of fragile site expression has been elusive. We demonstrate that the replication checkpoint kinase ATR, but not ATM, is critical for maintenance of fragile site stability. ATR deficiency results in fragile site expression with and without addition of replication inhibitors. Thus, we propose that fragile sites are unreplicated chromosomal regions resulting from stalled forks that escape the ATR replication checkpoint. These findings have important implications for understanding both the mechanism of fragile site instability and the consequences of stalled replication in mammalian cells.
doi_str_mv 10.1016/S0092-8674(02)01113-3
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_18646842</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0092867402011133</els_id><sourcerecordid>18646842</sourcerecordid><originalsourceid>FETCH-LOGICAL-c491t-729af4ebaea0dd76f881f94aacd552c791a06b325c9be10cbb75bf36e779a2fc3</originalsourceid><addsrcrecordid>eNqFkE1LAzEQhoMotn78BKUHET2sTrKbZHOSUqwKBaGt55BkZ0tk263JrtB_7_YDPXqZuTzvvMxDyBWFBwpUPM4AFEtyIbM7YPdAKU2T9Ij0KSiZZFSyY9L_RXrkLMZPAMg556ekRxlnIgfeJzfD-XQwxUVbmQbjYBzMwlc4mPmmG42xvvLN5oKclKaKeHnY5-Rj_DwfvSaT95e30XCSuEzRJpFMmTJDa9BAUUhR5jktVWaMKzhnTipqQNiUcacsUnDWSm7LVKCUyrDSpefkdn93HeqvFmOjlz46rCqzwrqNmuYiE3nGOpDvQRfqGAOWeh380oSNpqC3evROj97-roHpnR6ddrnrQ0Frl1j8pQ4-OuBpD2D35rfHoKPzuHJY-ICu0UXt_6n4ATqtc1Y</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>18646842</pqid></control><display><type>article</type><title>ATR Regulates Fragile Site Stability</title><source>MEDLINE</source><source>Cell Press Free Archives</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Access via ScienceDirect (Elsevier)</source><creator>Casper, Anne M. ; Nghiem, Paul ; Arlt, Martin F. ; Glover, Thomas W.</creator><creatorcontrib>Casper, Anne M. ; Nghiem, Paul ; Arlt, Martin F. ; Glover, Thomas W.</creatorcontrib><description>Conditions that partially inhibit DNA replication induce expression of common fragile sites. These sites form gaps and breaks on metaphase chromosomes and are deleted and rearranged in many tumors. Yet, the mechanism of fragile site expression has been elusive. We demonstrate that the replication checkpoint kinase ATR, but not ATM, is critical for maintenance of fragile site stability. ATR deficiency results in fragile site expression with and without addition of replication inhibitors. Thus, we propose that fragile sites are unreplicated chromosomal regions resulting from stalled forks that escape the ATR replication checkpoint. These findings have important implications for understanding both the mechanism of fragile site instability and the consequences of stalled replication in mammalian cells.</description><identifier>ISSN: 0092-8674</identifier><identifier>EISSN: 1097-4172</identifier><identifier>DOI: 10.1016/S0092-8674(02)01113-3</identifier><identifier>PMID: 12526805</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>2-Aminopurine - pharmacology ; Antimetabolites - pharmacology ; Aphidicolin - pharmacology ; Ataxia Telangiectasia Mutated Proteins ; Blotting, Western ; Caffeine - pharmacology ; Cell Cycle Proteins - physiology ; Cells, Cultured ; Chromosome Fragile Sites ; Chromosome Fragility ; Chromosomes - drug effects ; DNA - biosynthesis ; DNA-Binding Proteins ; Dose-Response Relationship, Drug ; HeLa Cells ; Humans ; Metaphase ; Microscopy, Fluorescence ; Models, Biological ; Phosphodiesterase Inhibitors - pharmacology ; Protein-Serine-Threonine Kinases - metabolism ; Tumor Suppressor Proteins</subject><ispartof>Cell, 2002-12, Vol.111 (6), p.779-789</ispartof><rights>2002 Cell Press</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c491t-729af4ebaea0dd76f881f94aacd552c791a06b325c9be10cbb75bf36e779a2fc3</citedby><cites>FETCH-LOGICAL-c491t-729af4ebaea0dd76f881f94aacd552c791a06b325c9be10cbb75bf36e779a2fc3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0092-8674(02)01113-3$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12526805$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Casper, Anne M.</creatorcontrib><creatorcontrib>Nghiem, Paul</creatorcontrib><creatorcontrib>Arlt, Martin F.</creatorcontrib><creatorcontrib>Glover, Thomas W.</creatorcontrib><title>ATR Regulates Fragile Site Stability</title><title>Cell</title><addtitle>Cell</addtitle><description>Conditions that partially inhibit DNA replication induce expression of common fragile sites. These sites form gaps and breaks on metaphase chromosomes and are deleted and rearranged in many tumors. Yet, the mechanism of fragile site expression has been elusive. We demonstrate that the replication checkpoint kinase ATR, but not ATM, is critical for maintenance of fragile site stability. ATR deficiency results in fragile site expression with and without addition of replication inhibitors. Thus, we propose that fragile sites are unreplicated chromosomal regions resulting from stalled forks that escape the ATR replication checkpoint. These findings have important implications for understanding both the mechanism of fragile site instability and the consequences of stalled replication in mammalian cells.</description><subject>2-Aminopurine - pharmacology</subject><subject>Antimetabolites - pharmacology</subject><subject>Aphidicolin - pharmacology</subject><subject>Ataxia Telangiectasia Mutated Proteins</subject><subject>Blotting, Western</subject><subject>Caffeine - pharmacology</subject><subject>Cell Cycle Proteins - physiology</subject><subject>Cells, Cultured</subject><subject>Chromosome Fragile Sites</subject><subject>Chromosome Fragility</subject><subject>Chromosomes - drug effects</subject><subject>DNA - biosynthesis</subject><subject>DNA-Binding Proteins</subject><subject>Dose-Response Relationship, Drug</subject><subject>HeLa Cells</subject><subject>Humans</subject><subject>Metaphase</subject><subject>Microscopy, Fluorescence</subject><subject>Models, Biological</subject><subject>Phosphodiesterase Inhibitors - pharmacology</subject><subject>Protein-Serine-Threonine Kinases - metabolism</subject><subject>Tumor Suppressor Proteins</subject><issn>0092-8674</issn><issn>1097-4172</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1LAzEQhoMotn78BKUHET2sTrKbZHOSUqwKBaGt55BkZ0tk263JrtB_7_YDPXqZuTzvvMxDyBWFBwpUPM4AFEtyIbM7YPdAKU2T9Ij0KSiZZFSyY9L_RXrkLMZPAMg556ekRxlnIgfeJzfD-XQwxUVbmQbjYBzMwlc4mPmmG42xvvLN5oKclKaKeHnY5-Rj_DwfvSaT95e30XCSuEzRJpFMmTJDa9BAUUhR5jktVWaMKzhnTipqQNiUcacsUnDWSm7LVKCUyrDSpefkdn93HeqvFmOjlz46rCqzwrqNmuYiE3nGOpDvQRfqGAOWeh380oSNpqC3evROj97-roHpnR6ddrnrQ0Frl1j8pQ4-OuBpD2D35rfHoKPzuHJY-ICu0UXt_6n4ATqtc1Y</recordid><startdate>20021213</startdate><enddate>20021213</enddate><creator>Casper, Anne M.</creator><creator>Nghiem, Paul</creator><creator>Arlt, Martin F.</creator><creator>Glover, Thomas W.</creator><general>Elsevier Inc</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TM</scope></search><sort><creationdate>20021213</creationdate><title>ATR Regulates Fragile Site Stability</title><author>Casper, Anne M. ; Nghiem, Paul ; Arlt, Martin F. ; Glover, Thomas W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c491t-729af4ebaea0dd76f881f94aacd552c791a06b325c9be10cbb75bf36e779a2fc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>2-Aminopurine - pharmacology</topic><topic>Antimetabolites - pharmacology</topic><topic>Aphidicolin - pharmacology</topic><topic>Ataxia Telangiectasia Mutated Proteins</topic><topic>Blotting, Western</topic><topic>Caffeine - pharmacology</topic><topic>Cell Cycle Proteins - physiology</topic><topic>Cells, Cultured</topic><topic>Chromosome Fragile Sites</topic><topic>Chromosome Fragility</topic><topic>Chromosomes - drug effects</topic><topic>DNA - biosynthesis</topic><topic>DNA-Binding Proteins</topic><topic>Dose-Response Relationship, Drug</topic><topic>HeLa Cells</topic><topic>Humans</topic><topic>Metaphase</topic><topic>Microscopy, Fluorescence</topic><topic>Models, Biological</topic><topic>Phosphodiesterase Inhibitors - pharmacology</topic><topic>Protein-Serine-Threonine Kinases - metabolism</topic><topic>Tumor Suppressor Proteins</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Casper, Anne M.</creatorcontrib><creatorcontrib>Nghiem, Paul</creatorcontrib><creatorcontrib>Arlt, Martin F.</creatorcontrib><creatorcontrib>Glover, Thomas W.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Nucleic Acids Abstracts</collection><jtitle>Cell</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Casper, Anne M.</au><au>Nghiem, Paul</au><au>Arlt, Martin F.</au><au>Glover, Thomas W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>ATR Regulates Fragile Site Stability</atitle><jtitle>Cell</jtitle><addtitle>Cell</addtitle><date>2002-12-13</date><risdate>2002</risdate><volume>111</volume><issue>6</issue><spage>779</spage><epage>789</epage><pages>779-789</pages><issn>0092-8674</issn><eissn>1097-4172</eissn><abstract>Conditions that partially inhibit DNA replication induce expression of common fragile sites. These sites form gaps and breaks on metaphase chromosomes and are deleted and rearranged in many tumors. Yet, the mechanism of fragile site expression has been elusive. We demonstrate that the replication checkpoint kinase ATR, but not ATM, is critical for maintenance of fragile site stability. ATR deficiency results in fragile site expression with and without addition of replication inhibitors. Thus, we propose that fragile sites are unreplicated chromosomal regions resulting from stalled forks that escape the ATR replication checkpoint. These findings have important implications for understanding both the mechanism of fragile site instability and the consequences of stalled replication in mammalian cells.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>12526805</pmid><doi>10.1016/S0092-8674(02)01113-3</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0092-8674
ispartof Cell, 2002-12, Vol.111 (6), p.779-789
issn 0092-8674
1097-4172
language eng
recordid cdi_proquest_miscellaneous_18646842
source MEDLINE; Cell Press Free Archives; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Access via ScienceDirect (Elsevier)
subjects 2-Aminopurine - pharmacology
Antimetabolites - pharmacology
Aphidicolin - pharmacology
Ataxia Telangiectasia Mutated Proteins
Blotting, Western
Caffeine - pharmacology
Cell Cycle Proteins - physiology
Cells, Cultured
Chromosome Fragile Sites
Chromosome Fragility
Chromosomes - drug effects
DNA - biosynthesis
DNA-Binding Proteins
Dose-Response Relationship, Drug
HeLa Cells
Humans
Metaphase
Microscopy, Fluorescence
Models, Biological
Phosphodiesterase Inhibitors - pharmacology
Protein-Serine-Threonine Kinases - metabolism
Tumor Suppressor Proteins
title ATR Regulates Fragile Site Stability
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T02%3A26%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=ATR%20Regulates%20Fragile%20Site%20Stability&rft.jtitle=Cell&rft.au=Casper,%20Anne%20M.&rft.date=2002-12-13&rft.volume=111&rft.issue=6&rft.spage=779&rft.epage=789&rft.pages=779-789&rft.issn=0092-8674&rft.eissn=1097-4172&rft_id=info:doi/10.1016/S0092-8674(02)01113-3&rft_dat=%3Cproquest_cross%3E18646842%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=18646842&rft_id=info:pmid/12526805&rft_els_id=S0092867402011133&rfr_iscdi=true